214 related articles for article (PubMed ID: 30557060)
21. Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles.
Gumireddy A; Christman R; Kumari D; Tiwari A; North EJ; Chauhan H
AAPS PharmSciTech; 2019 Mar; 20(4):145. PubMed ID: 30887133
[TBL] [Abstract][Full Text] [Related]
22. Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies.
Sabapati M; Palei NN; C K AK; Molakpogu RB
Drug Dev Ind Pharm; 2019 Apr; 45(4):577-586. PubMed ID: 30663427
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of novel P(HEMA-LA-MADQUAT) micelles for co-delivery of methotrexate and Chrysin in combination cancer chemotherapy.
Davaran S; Fazeli H; Ghamkhari A; Rahimi F; Molavi O; Anzabi M; Salehi R
J Biomater Sci Polym Ed; 2018 Aug; 29(11):1265-1286. PubMed ID: 29560796
[TBL] [Abstract][Full Text] [Related]
24. Nanoscale modification of chrysin for improved of therapeutic efficiency and cytotoxicity.
Sulaiman GM; Jabir MS; Hameed AH
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):708-720. PubMed ID: 29383946
[TBL] [Abstract][Full Text] [Related]
25. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
26. Morin hydrate loaded solid lipid nanoparticles: Characterization, stability, anticancer activity, and bioavailability.
Karamchedu S; Tunki L; Kulhari H; Pooja D
Chem Phys Lipids; 2020 Nov; 233():104988. PubMed ID: 33035545
[TBL] [Abstract][Full Text] [Related]
27. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation.
Rajpoot K; Jain SK
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1236-1247. PubMed ID: 28849671
[TBL] [Abstract][Full Text] [Related]
29. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation.
Wang L; Li H; Wang S; Liu R; Wu Z; Wang C; Wang Y; Chen M
AAPS PharmSciTech; 2014 Aug; 15(4):834-44. PubMed ID: 24696391
[TBL] [Abstract][Full Text] [Related]
30. Development of Houttuynia cordata Extract-Loaded Solid Lipid Nanoparticles for Oral Delivery: High Drug Loading Efficiency and Controlled Release.
Kim JH; Baek JS; Park JK; Lee BJ; Kim MS; Hwang SJ; Lee JY; Cho CW
Molecules; 2017 Dec; 22(12):. PubMed ID: 29236057
[No Abstract] [Full Text] [Related]
31. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
[TBL] [Abstract][Full Text] [Related]
33. Metal ion-assisted drug-loading model for novel delivery system of cisplatin solid lipid nanoparticles with improving loading efficiency and sustained release.
Yang C; Lv J; Lv T; Pan Y; Han Y; Zhao S; Wang J
J Microencapsul; 2016 May; 33(3):292-8. PubMed ID: 27113257
[TBL] [Abstract][Full Text] [Related]
34. Capsaicin-loaded solid lipid nanoparticles: design, biodistribution, in silico modeling and in vitro cytotoxicity evaluation.
Kunjiappan S; Sankaranarayanan M; Karan Kumar B; Pavadai P; Babkiewicz E; Maszczyk P; Glodkowska-Mrowka E; Arunachalam S; Ram Kumar Pandian S; Ravishankar V; Baskararaj S; Vellaichamy S; Arulmani L; Panneerselvam T
Nanotechnology; 2021 Feb; 32(9):095101. PubMed ID: 33113518
[TBL] [Abstract][Full Text] [Related]
35. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
36. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
37. Directional modification of chrysin for exerting apoptosis and enhancing significantly anti-cancer effects of 10-hydroxy camptothecin.
Tang Q; Ji F; Guo J; Wang J; Li Y; Bao Y
Biomed Pharmacother; 2016 Aug; 82():693-703. PubMed ID: 27470413
[TBL] [Abstract][Full Text] [Related]
38. Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells.
Niazvand F; Orazizadeh M; Khorsandi L; Abbaspour M; Mansouri E; Khodadadi A
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31013662
[No Abstract] [Full Text] [Related]
39. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.
Parveen R; Ahmad FJ; Iqbal Z; Samim M; Ahmad S
Drug Dev Ind Pharm; 2014 Sep; 40(9):1206-12. PubMed ID: 23826860
[TBL] [Abstract][Full Text] [Related]
40. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
